Jangee Flexibilis (Drospirenone, Ethinylestradiol)

Jangee Flexibilis, a combined oral contraceptive, is used within the hormonal contraception pathway to prevent pregnancy.

• Contraception: provides reliable prevention of unintended pregnancy in women of childbearing potential.
• Family planning: enables controlled timing of pregnancies for individuals and couples.
• Birth control: reduces the risk of accidental conception during regular sexual activity.

• Drospirenone/Ethinylestradiol works by suppressing the mid‑cycle surge of luteinizing hormone (LH) and follicle‑stimulating hormone (FSH), thereby inhibiting ovulation. It also thickens cervical mucus and induces endometrial changes that make implantation unlikely, delivering effective hormonal contraception.

Jangee Flexibilis may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Nausea: occasional stomach upset, especially when first starting therapy.
• Headache: mild to moderate tension‑type headaches.
• Breast tenderness: temporary swelling or discomfort of the breasts.
• Spotting: irregular light bleeding between periods.

Serious or Rare Side Effects

• Venous thromboembolism: blood clots in deep veins, potentially life‑threatening.
• Stroke: rare cerebrovascular event, more likely in high‑risk individuals.
• Pulmonary embolism: clot migration to the lungs, requiring urgent care.
• Severe allergic reaction: rash, swelling, or difficulty breathing.
• Hyperkalemia: elevated potassium levels due to drospirenone’s antimineralocorticoid activity.

Before prescribing Jangee Flexibilis, clinicians should evaluate several safety considerations.

• Assess cardiovascular risk: review history of thromboembolic events or clotting disorders.
• Screen for hypertension: monitor blood pressure regularly during treatment.
• Check liver function: avoid use in severe hepatic impairment.
• Avoid smoking: especially in women over 35 years of age.
• Review concomitant medications: consider potential drug interactions.
• Store at ambient temperature: keep below 25°C in the original pack, protect from moisture.

Jangee Flexibilis can interact with other medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid)

• Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): may markedly reduce contraceptive efficacy.
• Antifungal agents (e.g., itraconazole): can increase hormone levels, raising side‑effect risk.
• Protease inhibitors (e.g., ritonavir): may affect hormone metabolism.

Moderate Interactions (Monitor Closely)

• SSRIs (e.g., fluoxetine): may increase risk of mood changes.
• Antihypertensives (e.g., spironolactone): additive effect on potassium balance.
• St. John’s wort: herbal inducer that can lower contraceptive effectiveness.